T-Ray Science, Inc. is a medical device company centered on the development and commercialization of an innovative skin cancer detection system for the early diagnosis and treatment of all significant forms of skin cancer.  (Including: melanoma, basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)). 

The Company’s patented imaging and spectroscopy technologies are the foundation for the development of the company’s non-invasive, in vivo skin cancer detection and delineation system. This diagnostic tool will deliver significant clinical impact through improved patient outcomes, and will reduce healthcare costs by eliminating the need for most biopsies. The platform technology is extensible to other forms of cancer including lung and cervical cancers.

T-Ray continues to build a portfolio of OEM and out-licensing agreements to support numerous research and commercial applications.